Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20020 (
adenosine triphosphatase
)
3,299
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effects of salinomycin on alkali cation transport and membrane functions in rat liver mitochondria have been investigated. After potassium uptake, stimulated by valinomycin or monazomycin in the presence of adenosine 5'-triphosphate, salinomycin caused rapid release of K(+) from mitochondria.
Salinomycin
reversed valinomycin- or monazomycin-induced oscillatory swelling of mitochondria preloaded with K(+), Rb(+), and Na(+) but was without effect on Li(+) or Cs(+) preloaded mitochondria.
Salinomycin
blocked the retention of K(+) more effectively than the retention of Rb(+) or Na(+).
Salinomycin
inhibited both coupled and uncoupled respiration with strict substrate specificity in medium of low but not in high K(+) concentration. The oxidation of glutamate, alpha-ketoglutarate, and malate plus pyruvate was inhibited by salinomycin, but that of beta-hydroxybutyrate or succinate was not significantly affected.
Salinomycin
inhibited
adenosine triphosphatase
activity of mitochondria induced by valinomycin or monazomycin in K(+) and Rb(+) medium without significantly affecting
adenosine triphosphatase
activity in Li(+), Na(+), or Cs(+) medium. Oxidative phosphorylation in mitochondria was inhibited by salinomycin but the inhibitory effect of salinomycin lacked the substrate specificity observed for respiration. It is proposed that salinomycin perturbs mitochondrial functions by acting as a mobile carrier for alkali cations through membranes.
...
PMID:Salinomycin effects on mitochondrial ion translocation and respiration. 13 9